Related references
Note: Only part of the references are listed.Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
J. W. Valle et al.
ANNALS OF ONCOLOGY (2014)
Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma
Do Hyun Park et al.
EUROPEAN JOURNAL OF CANCER (2014)
Long-Term Outcome of Photodynamic Therapy with Systemic Chemotherapy Compared to Photodynamic Therapy Alone in Patients with Advanced Hilar Cholangiocarcinoma
Mi Jin Hong et al.
GUT AND LIVER (2014)
Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted
Jayant P. Talreja et al.
CLINICAL ENDOSCOPY (2013)
Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival Analysis
M. Knueppel et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Combination of Bilateral Metal Stenting and Trans-Stent Photodynamic Therapy for Palliative Treatment of Hilar Cholangiocarcinoma
T. Gerhardt et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2010)
Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice
David Fuks et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Single-agent gemcitabine for biliary tract cancers - Study outcomes and systematic review of the literature
Takayoshi Kiba et al.
ONCOLOGY (2006)
Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study
MEJ Ortner et al.
GASTROENTEROLOGY (2003)
Review of gemcitabine in biliary tract carcinoma
W Scheithauer
SEMINARS IN ONCOLOGY (2002)
Share Paper
